Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
temozolomide (temodar) (1 trial)
tvi-brain-1 (4 trials)
aldesleukin (Proleukin) (1 trial)
white blood cells (1 trial)
Astrocytoma (Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Trials (4 total)
Trial APIs (4 total)